| Primary |
| Sedation |
22.6% |
| Vitamin Supplementation |
17.0% |
| Anaesthesia Procedure |
11.3% |
| Diuretic Therapy |
11.3% |
| Hypertension |
11.3% |
| Mineral Supplementation |
11.3% |
| Airway Burns |
5.7% |
| Muscle Relaxant Therapy |
5.7% |
| Thermal Burn |
3.8% |
|
| Toxic Epidermal Necrolysis |
100.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
18.2% |
| Sedation |
14.0% |
| Antibiotic Therapy |
7.7% |
| Product Used For Unknown Indication |
7.0% |
| Antibiotic Level |
6.3% |
| Anaesthesia |
4.2% |
| Eye Infection Fungal |
4.2% |
| Polyuria |
4.2% |
| Vitamin Supplementation |
4.2% |
| Hypertension |
3.5% |
| Muscle Relaxant Therapy |
3.5% |
| Otitis Externa |
3.5% |
| Blood Pressure Management |
2.8% |
| Chemotherapy |
2.8% |
| Diuretic Therapy |
2.8% |
| Pneumonia |
2.8% |
| Febrile Neutropenia |
2.1% |
| Liver Abscess |
2.1% |
| Peptic Ulcer |
2.1% |
| Thermal Burn |
2.1% |
|
| Drug Hypersensitivity |
30.8% |
| Toxic Epidermal Necrolysis |
19.2% |
| Leukoencephalopathy |
15.4% |
| Systemic Candida |
11.5% |
| Urticaria |
7.7% |
| Death |
3.8% |
| Haemorrhage |
3.8% |
| Otitis Externa |
3.8% |
| Pruritus |
3.8% |
|
| Concomitant |
| Prophylaxis |
19.7% |
| Product Used For Unknown Indication |
17.7% |
| Infection Prophylaxis |
14.6% |
| Bone Marrow Conditioning Regimen |
8.0% |
| Prophylaxis Against Graft Versus Host Disease |
6.2% |
| Premedication |
4.8% |
| Acute Lymphocytic Leukaemia |
3.9% |
| Drug Use For Unknown Indication |
3.9% |
| Acute Myeloid Leukaemia Recurrent |
3.2% |
| Antifungal Prophylaxis |
2.3% |
| Stem Cell Transplant |
2.1% |
| Ewing's Sarcoma Recurrent |
1.9% |
| Prophylaxis Of Nausea And Vomiting |
1.8% |
| Pain |
1.8% |
| Acute Myeloid Leukaemia |
1.7% |
| Pneumonia |
1.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.4% |
| Immunosuppression |
1.2% |
| Infection |
1.2% |
| Febrile Neutropenia |
1.1% |
|
| White Blood Cell Count Decreased |
13.4% |
| Sepsis |
11.8% |
| Stomatitis |
10.1% |
| Pyrexia |
8.4% |
| Thrombocytopenia |
7.6% |
| Weight Increased |
6.7% |
| Graft Versus Host Disease In Skin |
5.0% |
| Cytomegalovirus Infection |
4.2% |
| Thrombotic Microangiopathy |
4.2% |
| Blood Bilirubin Increased |
3.4% |
| Platelet Count Decreased |
3.4% |
| Venoocclusive Liver Disease |
3.4% |
| Acute Graft Versus Host Disease In Skin |
2.5% |
| Enterococcal Infection |
2.5% |
| Pneumonia |
2.5% |
| Pulmonary Alveolar Haemorrhage |
2.5% |
| Renal Impairment |
2.5% |
| Streptococcal Bacteraemia |
2.5% |
| Antithrombin Iii Decreased |
1.7% |
| Ascites |
1.7% |
|
